Growing acceptance of preclinical imaging as a legitimate drug development device is to propel the growth of Global Preclinical In-vivo Imaging Market

Posted on
by

re-clinical in-vivo imaging industry has experienced myriad technological advancements, changes in market due to industry consolidation, and change in government funding and support for research studies across the global over the past decade.

Market Overview:

The Global Preclinical in-vivo imaging market has been estimated at USD 714.17 Million in 2018 and is projected to reach USD 944.95 Million by 2023, at a CAGR of 5.76% all through the forecast period from 2018 to 2023. Preclinical imaging (In-VIVO) is used to study animal research for drug improvement. Preclinical imaging is similarly used to display the treatment reaction for early caution symptoms of efficacy. The technological development of in vivo imaging gives a possibility for reading sickness on the molecular level in a quantitative manner.

Request Report Sample:  https://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/request-sample

Factors affecting market growth:

  •  Technological advancement of imaging structures (+)
  •  Growing consciousness about the benefits of early disorder analysis (+)
  •  Rise in the rate of adoption of multi-modality imaging structures (+)
  •  Intensifying acceptance of preclinical imaging (+)
  •  Excessive cost of protection (-)
  •   Declining NIH budgets for medical science research studies (-)

Get your customized report:https://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/customize-report

Market Segmentation

The Global Preclinical in-vivo imaging market is segmented on the basis of

 By Modality                

  • Optical imaging      
    • Bioluminescence/fluorescence imaging systems
    • Standalone fluorescence imaging systems
    • Optical + X-ray/optical + CT imaging systems
  • Nuclear imaging    
    • Micro-PET systems (standalone PET, PET/CT, and PET/MRI)
    • Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)
    • Tri-modality (PET/SPECT/CT) imaging systems
  • Micro-MRI               
  • Micro-CT  
  • Micro-ultrasound 
  • Photoacoustic        
  • Magnetic particle imaging systems               

By Reagent                 

  • Optical imaging reagents   
    • Bioluminescent reagents
    • Fluorescent imaging reagents
  • Nuclear imaging reagents 
    • Preclinical PET tracers
    • Preclinical SPECT probes
  • MRI contrast agents            
  • Ultrasound contrast agents             
  • CT contrast agents               

 

Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/

Key players:

The leading players of the market include Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc.

Media Contact
Company Name: Market Data Forecast
Contact Person: Abhishek Shukla
Email: Send Email
Phone: +1-888-702-9626
Address:2nd Floor, Lakeview Plaza, Kavuri Hills, flimnagar
City: Hyderabad
State: Telangana
Country: India
Website: www.marketdataforecast.com/